Nurosym Announces Wearable VNS Device Amid Growing Neuromodulation Interest

Nurosym announces its wearable VNS device amid growing interest in non-invasive neuromodulation, drawing on Parasym's extensive clinical research into nervous system function, stress and recovery.

London, United Kingdom, November 3, 2026 /PressCable/ -- Nurosym, developed by Parasym, has announced its wearable vagus nerve stimulation (VNS) device amid growing interest in non-invasive neuromodulation. The CE-marked medical device uses proprietary technology to deliver gentle electrical pulses through the outer ear, bringing a clinically studied approach to everyday use.

The announcement comes as stress remains a widespread concern, drawing attention to research into nervous system function and recovery. According to Gallup's 2025 State of the World's Emotional Health report, 37% of adults worldwide experienced significant stress during the previous day.

Parasym's research programme includes more than sixty completed clinical studies, over one hundred ongoing studies and more than one hundred and fifty research partners. Its proprietary technology has been tested in randomised, placebo-controlled studies, contributing to the evidence base for auricular vagus nerve stimulation.

The research has examined several outcomes across specific study populations. In clinical studies, anxiety fell by an average of 35% and fatigue by 48%, while sleep quality improved by an average of 30%. These findings describe measured outcomes under research conditions, not guaranteed results for individual users.

“Research into auricular vagus nerve stimulation continues to develop, helping us understand how this approach interacts with different physiological functions. Our focus is on building that evidence through rigorous clinical investigation,” said Dr Elisabetta Burchi, Translational Research Lead at Parasym.

Nurosym uses Parasym's proprietary AVNT™ waveform through an earpiece positioned on the tragus, where a branch of the vagus nerve reaches the skin. The vagus nerve carries signals between the brain and organs, including the heart, lungs and gut, and plays an important role in stress and recovery.

The device is designed for everyday use, with typical sessions lasting approximately thirty minutes, once or twice daily. Its development draws on more than a decade of research and development into non-invasive neuromodulation.

Further details can be found at https://nurosym.com/

About Parasym

Parasym is a London-based neuromodulation company that develops wearable, non-invasive auricular vagus nerve stimulation devices using its proprietary AVNT™ technology. Its devices are marketed as Nurosym in the UK, Europe, and other international markets, and as Nuropod in the United States.

Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as medical claims or guaranteed individual outcomes. Nurosym is a CE-marked medical device in Europe.

Contact Info:
Name: PR Team
Email: Send Email
Organization: Nurosym by Parasym
Address: 18 Saint Cross Street 4th Floor, London, England EC1N 8UN, United Kingdom
Website: https://nurosym.com/

Source: PressCable

Release ID: 89208300

In case of identifying any errors, concerns, or inconsistencies within the content shared in this press release that necessitate action or if you require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team is committed to addressing your concerns within 8 hours by taking necessary actions diligently to rectify any identified issues or supporting you with the removal process. Delivering accurate and reliable information remains our top priority.